Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 51 (PPIAP51)

Target
PPIAP51
Molecular classification
Other (Pseudogene)
01

Overview

Peptidylprolyl isomerase A pseudogene 51 (PPIAP51) is a human pseudogene related to the gene encoding peptidylprolyl isomerase A (PPIA, cyclophilin A), a widely expressed protein involved in protein folding, immune modulation, and several cellular stress responses[1][2][3][4][5]. PPIAP51 itself does not encode a functional protein and is not considered a therapeutic target, receptor, enzyme, or transporter.

Other names
Peptidylprolyl isomerase A (cyclophilin A) pseudogenePPIAP51

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 51 (PPIAP51).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 51 (PPIAP51).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call